Innate Pharma IPHA Institutional Ownership

NASDAQ IPHA

$1.57 -0.01 (-0.51%)

At close: Oct 21, 2026 · 4:00 PM EDT

Institutions by Trading Activity

10 Institutions

Increased 5 50.0%

Unchanged 2 20.0%

Reduced 3 30.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

0.21%

▲+0.02 pp QoQ

Shares Held by Institutions

192.42K

of 89.59Mn outstanding

▲+4.60% QoQ

Shares Outstanding

89.59Mn

89.40Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+1 vs prior quarter

Net Shares Added (QoQ)

+8.47K

accumulated since last quarter

Value of Holdings

$304.02K

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 10, 2026

Innate Pharma SA (NASDAQ:IPHA) was held by 10 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

These investors held 0.21% of Innate Pharma's outstanding shares at the end of Q2 2026, up from 0.20% in Q1 2026.
Total shares held in Innate Pharma rose 4.60% from Q1 2026, while the number of holders rose 42.86% from Q2 2025.
Of these 10 holders, 5 added to their positions, 3 reduced their stakes and 2 left their positions unchanged.
The aggregate institutional position in Innate Pharma was 192.42K shares at the end of Q2 2026, up 8.47K from the prior quarter and up 170.42K from a year earlier.
Lion Point Capital, LP held the largest position in IPHA at 81.15K shares as of June 30, 2026, or 0.09% of shares outstanding.
Among holders that already owned Innate Pharma, the biggest buyers in Q2 2026 were UBS Group AG (+502 shares) and Farther Finance Advisors, LLC (+11 shares).
Among holders that kept a stake in Innate Pharma, the biggest sellers in Q2 2026 were Jane Street Group, LLC (-33.05K shares), GAMMA Investing LLC (-231 shares) and Rhumbline Advisers (-15 shares).
According to Business Quant data, the leading holders of IPHA for Q2 2026 were Lion Point Capital, LP (81.15K shares), Morgan Stanley (43.52K shares), SmartHarvest Portfolios, LLC (23.75K shares), XTX Topco Ltd (15.13K shares), Citadel Advisors LLC (12.44K shares), Jane Street Group, LLC (10.31K shares), Rhumbline Advisers (4.72K shares), UBS Group AG (1.36K shares), Farther Finance Advisors, LLC (21 shares) and GAMMA Investing LLC (9 shares).

Form 13F Holdings

10 Institutional Holders

Report period 30 Jun, 2026

Total shares held 192.42K

Of outstanding 0.21%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Lion Point Capital, LP	0001643354	81,151	0.09%	0	0.00%	$149.32K
2	Morgan Stanley	0000895421	43,524	0.05%	0	0.00%	$80.08K
3	SmartHarvest Portfolios, LLC	0002066604	23,750	0.03%	▲23,750	0.00%	$43.70K
4	XTX Topco Ltd	0001828301	15,130	0.02%	▲15,130	0.00%	$27.84K
5	CITADEL ADVISORS LLC	0001423053	12,441	0.01%	▲12,441	0.00%	$22.89K
6	JANE STREET GROUP, LLC	0001595888	10,310	0.01%	▼33,055	-76.23%	$18.97K
7	RHUMBLINE ADVISERS	0001115418	4,719	0.01%	▼15	-0.32%	$8.68K
8	UBS Group AG	0001610520	1,363	0.00%	▲502	+58.30%	$2.51K
9	Farther Finance Advisors, LLC	0001992825	21	0.00%	▲11	+110.00%	$38
10	GAMMA Investing LLC	0002010235	9	0.00%	▼231	-96.25%	$17